A reasonable chance it could cause serious harm or death.
Labeling: Label Error on Declared Strength; Some cartons were incorrectly labeled as 0.125 mg instead of 0.25 mg. The blister strips inside the product carton reflect the correct strength of 0.25 mg.
| Brand name | CLONAZEPAM |
| Generic name | CLONAZEPAM |
| Active ingredient(s) | CLONAZEPAM |
| Distributed by / for | Par Pharmaceutical, Chestnut Ridge, NY 10977 |
| NDC | 49884-306-02 |
| Full product label | Clonazepam Orally Disintegrating Tablets, USP (C-IV) 0.125mg, 60 tablets per carton (10 blister cards containing 6 tablets each), Rx Only, Distributed by: Par Pharmaceutical, Chestnut Ridge, NY 10977, NDC# 49884-306-02. |
| Recalling firm | Endo Pharmaceuticals, Inc. |
| Distribution | Nationwide in the USA and Puerto Rico |
| Quantity | 8,139 cartons |
| Recall initiated | 2024-07-10 |
| Report date | 2024-08-07 |
| Recall completed | 2025-09-16 |
| Recall number | D-0622-2024 |
| Classification | Class I |
| FDA status | Terminated |
| Origin on file | Malvern PA United States |
Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗